Login
$BCRX
$7.71 +$0.26 (3.46%) After hours

$BCRX SEC Filings

Filed On Filing
10 Nov 2026 SCHEDULE 13G
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

— Maintained Full Year 2026 ORLADEYO revenue guidance of $625 to $645 million and increased total revenue guidance to $715 million to $730 million —

02 Sep 2026 Form 4: Stonehouse Jon P, Director

Received 644 shares as a grant or award ($6.25K)

02 Sep 2026 Form 4: Milne Jill C., Director

Received 1,288 shares as a grant or award ($12.5K)

02 Sep 2026 Form 4: Milano Vincent, Director

Received 1,159 shares as a grant or award ($11.2K)

02 Sep 2026 Form 4: McKee Amy E, Director

Received 644 shares as a grant or award ($6.25K)

02 Sep 2026 Form 4: Frank Steven, Director

Received 1,288 shares as a grant or award ($12.5K)

14 Aug 2026 SCHEDULE 13G/A
07 Aug 2026 SCHEDULE 13G
05 Aug 2026 FORM S-8
05 Aug 2026 10-Q
05 Aug 2026 8-K: Results of Operations and Financial Condition; Regulation FD Disclosure

— Maintained Full Year 2026 ORLADEYO revenue guidance of $625 to $645 million and increased total revenue guidance to $690 million to $715 million —

04 Aug 2026 8-K/A: Costs Associated with Exit or Disposal Activities

On June 29, 2026, the Company announced its plan to discontinue the Company’s internal discovery programs and close its Discovery Center of Excellence facility in Birmingham, Alabama (the “Plan”) as part of the Company’s ongoing strategi...

29 Jun 2026 8-K: Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure

BioCryst Sharpens Scientific Focus on External Innovation with Wind Down of Internal Discovery Programs and Closure of Birmingham Research Facility

15 Jun 2026 Form 4: Milne Jill C., Director

Received 15,294 shares as a grant or award · Granted 33,540 Automatic Stock Option Grant

15 Jun 2026 Form 4: Galson Steven K, Director

Received 15,294 shares as a grant or award · Granted 33,540 Automatic Stock Option Grant

15 Jun 2026 Form 4: Levin Alan G, Director

Received 15,294 shares as a grant or award · Granted 33,540 Automatic Stock Option Grant

15 Jun 2026 Form 4: Frank Steven, Director

Received 15,294 shares as a grant or award · Granted 33,540 Automatic Stock Option Grant

15 Jun 2026 Form 4: Sanders Machelle, Director

Received 15,294 shares as a grant or award · Granted 33,540 Automatic Stock Option Grant

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support